Apremilast for the treatment of a liver disease or a liver function abnormality
US10300042B2 · kind B2 · utility
0Cited by
76References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2015 |
| Grant date | May 28, 2019 |
| Priority date | — |
| Expiry date | Aug 29, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating, managing or preventing liver disease are disclosed. Specific methods encompass the administration of apremilast, alone or in combination with additional active agents or treatment regimens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.